Pierre Gravier

Insider Reports History

Location
South Plainfield, NJ
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pierre Gravier:

Form 4 holding CHIEF FINANCIAL OFFICER

PTC THERAPEUTICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
50,000
Estimated value
$1,521,563
Report date
02 Jan 2026
Price
$27.05
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CASSAVA SCIENCES INC

Security class
Stock Option (Right to Buy)
Shares / value
26,500
Estimated value
$168,700
Report date
23 May 2025
Price
$16.87
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Pierre Gravier

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .